Cargando…

Change in inhaled corticosteroid treatment and COPD exacerbations: an analysis of real-world data from the KOLD/KOCOSS cohorts

BACKGROUND: This cohort study of patients with chronic obstructive pulmonary disease (COPD) was performed to evaluate the status of inhaled corticosteroid (ICS) prescriptions following the 2017 revision of the Global Initiative for Chronic Obstructive Lung Disease guidelines. METHODS: A total of 114...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Se Hee, Lee, Ji-Hyun, Yoon, Ho Il, Park, Hye Yun, Kim, Tae-Hyung, Yoo, Kwang Ha, Oh, Yeon-Mok, Jung, Ki Suk, Lee, Sang-Do, Lee, Sei Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437901/ https://www.ncbi.nlm.nih.gov/pubmed/30922302 http://dx.doi.org/10.1186/s12931-019-1029-7

Ejemplares similares

Air Trapping and the Risk of COPD Exacerbation: Analysis From Prospective KOCOSS Cohort
por: Kim, Youlim, et al.
Publicado: (2022)

Adherence to the GOLD Guideline in COPD Management of South Korea: Findings from KOCOSS Study 2011–2018
por: Kim, Tae-Ok, et al.
Publicado: (2019)

Study Design and Outcomes of Korean Obstructive Lung Disease (KOLD) Cohort Study
por: Park, Tai Sun, et al.
Publicado: (2014)

Clinical Characteristics of Chronic Obstructive Pulmonary Disease in Female Patients: Findings from a KOCOSS Cohort
por: Choi, Joon Young, et al.
Publicado: (2020)

The Association Between Eosinophil Variability Patterns and the Efficacy of Inhaled Corticosteroids in Stable COPD Patients
por: Yoon, Jung-Ki, et al.
Publicado: (2020)

Radiographic Phenotypes Affect the Risk of Inhaled Corticosteroid-Associated Pneumonia in Patients with COPD
por: Lee, Hyo Jin, et al.
Publicado: (2022)

Inhaled Corticosteroids in Asthma and the Risk of Pneumonia
por: Kim, Min-Hye, et al.
Publicado: (2019)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
por: Siddiqui, Salman H, et al.
Publicado: (2018)

Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality
por: Oshagbemi, Olorunfemi A., et al.
Publicado: (2018)

Inhaled Corticosteroid use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study
por: Morjaria, Jaymin B., et al.
Publicado: (2017)

Comparison of Korean COPD Guideline and GOLD Initiative Report in Term of Acute Exacerbation: A Validation Study for Korean COPD Guideline
por: Hwang, Yong Il, et al.
Publicado: (2014)

Lack of Association between Inhaled Corticosteroid Use and the Risk of Future Exacerbation in Patients with GOLD Group A Chronic Obstructive Pulmonary Disease
por: Shin, Sun Hye, et al.
Publicado: (2022)

Comparison of pneumonia incidence between long-acting muscarinic antagonist and inhaled corticosteroid plus long-acting beta agonist in patients with COPD
por: Lee, Eung Gu, et al.
Publicado: (2023)

Exhaled Nitric Oxide in Patients with Stable Chronic Obstructive Pulmonary Disease: Clinical Implications of the Use of Inhaled Corticosteroids
por: Jo, Yong Suk, et al.
Publicado: (2020)

Addition of Montelukast to Low-Dose Inhaled Corticosteroid Leads to Fewer Exacerbations in Older Patients Than Medium-Dose Inhaled Corticosteroid Monotherapy
por: Ye, Young-Min, et al.
Publicado: (2015)

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
por: Vestbo, Jørgen, et al.
Publicado: (2019)

Inhaled corticosteroids in COPD and the risk for coronary heart disease: a nationwide cohort study
por: Shin, Jiyoung, et al.
Publicado: (2020)

Factors associated with exacerbation in mild- to-moderate COPD patients
por: Kim, Joo Kyung, et al.
Publicado: (2016)

Prediction of first acute exacerbation using COPD subtypes identified by cluster analysis
por: Yoon, Hee-Young, et al.
Publicado: (2019)

Outcome of Inhaler Withdrawal in Patients Receiving Triple Therapy for COPD
por: Kim, Sae Ahm, et al.
Publicado: (2016)

COPD Exacerbation-Related Pathogens and Previous COPD Treatment
por: Sim, Yun Su, et al.
Publicado: (2022)

Inhaled Corticosteroids and the Lung Microbiome in COPD
por: Keir, Holly R., et al.
Publicado: (2021)

The Impact of Inhaled Corticosteroids on the Prognosis of Chronic Obstructive Pulmonary Disease
por: Park, Ji Won, et al.
Publicado: (2023)

Comparison of COPD Assessment Test and Clinical COPD Questionnaire to predict the risk of exacerbation
por: Jo, Yong Suk, et al.
Publicado: (2017)

Inhaled corticosteroids in COPD and the risk of serious pneumonia
por: Suissa, Samy, et al.
Publicado: (2013)

Inhaled corticosteroids in COPD: Personalising the therapeutic choice
por: Shaw, J A, et al.
Publicado: (2018)

How inhaled corticosteroids target inflammation in COPD
por: Lea, Simon, et al.
Publicado: (2023)

Rational use of inhaled corticosteroids for the treatment of COPD
por: Quint, Jennifer K., et al.
Publicado: (2023)

The sputum transcriptome better predicts COPD exacerbations after the withdrawal of inhaled corticosteroids than sputum eosinophils
por: Ditz, Benedikt, et al.
Publicado: (2021)

Increased Risk of Exacerbation in Asthma Predominant Asthma–Chronic Obstructive Pulmonary Disease Overlap Syndrome
por: Park, Jisoo, et al.
Publicado: (2018)

Nebulized corticosteroids in the management of acute exacerbation of COPD
por: Gaude, G. S., et al.
Publicado: (2010)

Association of blood eosinophils and plasma periostin with FEV(1) response after 3-month inhaled corticosteroid and long-acting beta(2)-agonist treatment in stable COPD patients
por: Park, Hye Yun, et al.
Publicado: (2015)

Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations
por: Calverley, Peter M, et al.
Publicado: (2016)

Inhaled corticosteroid withdrawal may improve outcomes in elderly patients with COPD exacerbation: a nationwide database study
por: Jo, Taisuke, et al.
Publicado: (2020)

Discrete event simulation modelling for an improved patient flow at the Emergency Department, Sygehus Lillebælt, Kolding
por: Kozlowski, Dawid, et al.
Publicado: (2012)

Discrete event simulation modelling for an improved patient flow at the Emergency Department, Sygehus Lillebælt, Kolding
por: Kozlowski, Dawid, et al.
Publicado: (2012)

Three-month Treatment Response and Exacerbation in Chronic Obstructive Pulmonary Disease
por: Lee, Jung Su, et al.
Publicado: (2015)

Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms
por: Avdeev, Sergey, et al.
Publicado: (2019)

Inhaled corticosteroids and angiotensin-converting enzyme-2 in COPD
por: Lipworth, Brian, et al.
Publicado: (2021)

Association of body mass index and COPD exacerbation among patients with chronic bronchitis
por: Shin, Sun Hye, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t2vonj6og23pc56geer45m8426